Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-11, Stock:ABBV, The news for the past five days is as follows:
2019-10-04: NEWS1: Medical stocks on the move: AbbVie, Arrowhead Pharmaceuticals and Zynex.NEWS2: 5 Excellent GARP Picks Based on Discounted PEG.NEWS3: The Zacks Analyst Blog Highlights: Cintas, Air Products, Walmart, Target and AbbVie.
2019-10-07: NEWS1: AbbVie (ABBV) Stock Moves -0.44%: What You Should Know.NEWS2: 'Fast Money Halftime Report' Traders Advise Viewers On AbbVie, Home Depot And More.NEWS3: 3 Long-Term Dividend Payers Grant a High Forward Yield.NEWS4: Income Investors Should Know That AbbVie Inc. (NYSE:ABBV) Goes Ex-Dividend Soon.
2019-10-08: NEWS1: Were Hedge Funds Right About Snapping Up AbbVie Inc (ABBV)?.NEWS2: UPDATE 2-Humira, Rituxan top list of U.S. drugs with biggest price increases -report.NEWS3: AbbVie to Host Third-Quarter 2019 Earnings Conference Call.
2019-10-09: NEWS1: J&J Ordered by Philadelphia Jury to Pay $8B in Risperdal Case.NEWS2: Gilead (GILD) Files NDA for RA Candidate Filgotinib in Japan.NEWS3: AbbVie Announces New Data from its Dermatology Portfolio and Pipeline at the 28th European Academy of Dermatology and Venereology (EADV) Congress.
2019-10-10: NEWS1: Why This Biotech Stock Was Bullish Enough To Relicense Its Own Drugs.NEWS2: J&J (JNJ) to Start Q3 Earnings Season for Pharma Sector.NEWS3: Top Ranked Income Stocks to Buy for October 10th.NEWS4: The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO.

Answer: Decrease